Pancreatic insulinoma combined with glucagon positive cell: A case report

Table 1 Blood test findings on admission

Albumin, g/dL	3.0 (3.9-4.9)
Total bilirubin, mg/dL	0.3 (0.2-1.0)
Aspartate aminotransferase, IU/L	7 (10-40)
Alanine aminotransferase, IU/L	7 (5-45)
Blood urea nitrogen, mg/dL	54 (7.2-20.0)
Creatinine, mg/dL	8.2 (0.5-1.1)
Sodium, mmol/L	131 (136-145)
Potassium, mmol/L	4.1 (3.6-4.8)
Chlorine, mmol/L	101 (99-109)
White blood cell, μL	8000 (3100-9500)
Hemoglobin, g/dL	9.9 (13.5-16.9)
Platelet /μL	23.6 × 104 (15.1-34.9)
Fasting blood sugar, mg/dL	290 (70-109)
Hemoglobin A1c	7.6% (4.3%-5.8%)
Insulin, μIU/mL	4860 (1.8-12.2)
C-peptide, ng/mL	14.87 (0.61-2.09)
Binding rate of anti-insulin antibodies	76.2% (< 0.4%)
Carcinoembryonic, ng/mL	7.8 (< 5.0)
Pancreatic cancer-associated antigen-2, U/mL	190 (< 150)

Renal function test results and fasting blood glucose level before starting dialysis. Values in parentheses are normal ranges in our institution. All data were collected during the fasting state.